SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019082
Filing Date
2022-05-10
Accepted
2022-05-10 08:01:53
Documents
79
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fusn-10q_20220331.htm   iXBRL 10-Q 2095571
2 EX-31.1 fusn-ex311_10.htm EX-31.1 20835
3 EX-31.2 fusn-ex312_11.htm EX-31.2 20886
4 EX-32.1 fusn-ex321_8.htm EX-32.1 9387
5 EX-32.2 fusn-ex322_7.htm EX-32.2 9384
  Complete submission text file 0001564590-22-019082.txt   9307965

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA fusn-20220331.xsd EX-101.SCH 67318
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fusn-20220331_cal.xml EX-101.CAL 57057
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fusn-20220331_def.xml EX-101.DEF 175984
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE fusn-20220331_lab.xml EX-101.LAB 503736
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fusn-20220331_pre.xml EX-101.PRE 362946
73 EXTRACTED XBRL INSTANCE DOCUMENT fusn-10q_20220331_htm.xml XML 1953196
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39344 | Film No.: 22907448
SIC: 2836 Biological Products, (No Diagnostic Substances)